Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes

The Omicron variant of SARS-CoV-2 has rapidly become the dominant strain worldwide due to its high transmissibility, although it appears to be less pathogenic than previous strains. However, individuals with hematological malignancy (HM) and COVID-19 remain susceptible to severe infection and mortal...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Wenjing, Zheng, Yizhou, Feng, Sizhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622671/
https://www.ncbi.nlm.nih.gov/pubmed/37928188
http://dx.doi.org/10.3389/fcimb.2023.1207225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622671/
https://www.ncbi.nlm.nih.gov/pubmed/37928188
http://dx.doi.org/10.3389/fcimb.2023.1207225

Ejemplares similares